ESPR
Esperion Strengthens Balance Sheet With Closing of Significant Refinancing Transactions
时间:2024-12-18 20:00:41 市场: 美股 综合
Esperion Announces $210 Million Convertible Debt Financing
时间:2024-12-13 19:00:00 市场: 美股 综合
Esperion Therapeutics Q3 Operating Expenses USD 67.658 Million
时间:2024-11-07 19:00:01 市场: 综合 美股
Esperion EU Partner Reports Final Real-World Results From Milos German Cohort Demonstrating Strong Increase in Ldl-C Goal Achievement With Addition of Bempedoic Acid
时间:2024-10-02 20:00:01 市场: 美股 综合
Esperion Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
时间:2024-09-26 04:30:00 市场: 美股 综合